Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells

Int Immunol. 2004 May;16(5):643-53. doi: 10.1093/intimm/dxh072. Epub 2004 Apr 5.

Abstract

The signal transduction of the cAMP/cAMP-dependent protein kinase [protein kinase A (PKA)] pathway through multiple receptors is critical for many processes in all cell types. In T cells, the engagement of both the TCR-CD3 complex and the CD28 co-stimulatory molecule also induces cAMP, and subsequently activates PKA. It is believed that elevation of cAMP levels in T cells is inhibitory of IL-2 production and T cell proliferation. However, the function and detailed signal transduction mechanisms of the cAMP/PKA pathway in naive T(h) cells are less well understood. In this study, we show that calcitonin gene-related peptide (CGRP) down-regulates IL-2 and IFN-gamma production and up-regulates IL-4 production to promote T(h)2 differentiation by moderate activation of the cAMP/PKA pathway via the CGRP receptor in the presence of a CD3/CD28 co-stimulation signal. The IL-4 production and transcriptional activation of T(h)2 cytokine mRNAs were also reproduced by the addition of a cAMP analogue, dibutyryl-cAMP, in CD3/CD28-stimulated naive T(h) cells. More interestingly, cAMP/PKA activation in naive T(h) cells stimulated with anti-CD3 plus anti-CD28 mAb is essential for inducing IL-4 production and promoting T(h)2 differentiation; in addition, NF-AT is a downstream effector of the cAMP/PKA signaling pathway. These findings indicate that the cAMP/PKA pathway transduces the critical activation signal to T(h)2 polarization by a CD3/CD28 co-stimulation signal and a PKA activating reagent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bucladesine / pharmacology
  • CD28 Antigens / immunology
  • CD3 Complex / immunology
  • Calcitonin Gene-Related Peptide / pharmacology
  • Cell Differentiation
  • Cyclic AMP / metabolism*
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / immunology
  • Down-Regulation
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology
  • Interleukin-2 / genetics
  • Interleukin-2 / immunology
  • Interleukin-4 / biosynthesis*
  • Interleukin-4 / genetics
  • Isoquinolines / pharmacology
  • Jurkat Cells
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NFATC Transcription Factors
  • Nuclear Proteins / genetics
  • Nuclear Proteins / immunology
  • RNA, Messenger / analysis
  • Signal Transduction* / drug effects
  • Signal Transduction* / genetics
  • Signal Transduction* / immunology
  • Sulfonamides / pharmacology
  • Th1 Cells / immunology
  • Th2 Cells / enzymology
  • Th2 Cells / immunology*
  • Transcription Factors / genetics
  • Transcription Factors / immunology
  • Up-Regulation

Substances

  • CD28 Antigens
  • CD3 Complex
  • DNA-Binding Proteins
  • Interleukin-2
  • Isoquinolines
  • NFATC Transcription Factors
  • Nuclear Proteins
  • RNA, Messenger
  • Sulfonamides
  • Transcription Factors
  • Interleukin-4
  • Bucladesine
  • Interferon-gamma
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases
  • Calcitonin Gene-Related Peptide
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide